Significant reductions in uninsured patients, in advanced-stage disease, especially in African-Americans
THURSDAY, July 2, 2020 (HealthDay News) — Expansion of Medicaid was associated with a reduction in the number of uninsured patients with breast cancer, according to a study published online July 1 in JAMA Surgery.
Justin M. Le Blanc, M.D., from the Yale University School of Medicine in New Haven, Connecticut, and colleagues characterized the link between breast cancer stage and race/ethnicity, age, and insurance status using data obtained from 2007 to 2016.
A total of 1,796,902 women were included in the study. The researchers found that 4.0 percent were uninsured or had Medicaid between 2012 and 2016. Among all races/ethnicities, reductions were seen in uninsured patients in expansion states (from 22.6 to 13.5 percent), and nonexpansion states (from 36.5 to 35.6 percent). There were reductions noted in advanced-stage disease from 21.8 to 19.3 percent in expansion states compared with 24.2 to 23.5 percent in nonexpansion states across all races. The incidence of advanced disease decreased from 24.6 to 21.6 percent among African-American patients in expansion states, while in nonexpansion states, it remained at approximately 27 percent (27.4 to 27.5 percent). The improvement was associated with a reduction in stage 3 diagnosis.
“Expansion of Medicaid was associated with a reduction in the number of uninsured patients with breast cancer and with decreased late-stage breast cancer presentation,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer
Cancer Survivors Have Lower Levels of Physical Activity
Childhood Cancer Survivors Often Have Mental Distress in Adulthood
Mindfulness, Tai Chi May Benefit Cancer Survivors
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL